
|Articles|May 1, 2008
- Volume 0 0
advertiserINDEX
Advertisement
Articles in this issue
over 17 years ago
productHOTLINEover 17 years ago
Motion Sickness: Calming the Waves of Upsetover 17 years ago
pharmacy Pet Peevesover 17 years ago
recruitment/RESOURCESover 17 years ago
canyouREADtheseRxs?over 17 years ago
Case Studiesover 17 years ago
DIABETESWATCHover 17 years ago
CHOLESTEROLWATCHover 17 years ago
compoundingHOTLINEover 17 years ago
ARTHRITISWATCHNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5

















































































































































































































